期刊文献+

基质金属蛋白酶-1及其抑制因子-1与妊娠期高血压疾病的研究 被引量:3

Study of matrix metallopreteinases-1 and tissue inhibitor of metalloproteinases-1 and the pathogenesis of hypertensive disorder complicating pregnancy
原文传递
导出
摘要 目的探讨胎盘及脐血中基质金属蛋白酶-1(matrix metalloproteinases,MMP-1)及其抑制因子-1(tissue Inhibitor of metalloproteinases-1,TIMP-1)表达与妊娠期高血压疾病(hypertensive disorder complicating pregnancy,HDCP)发生及疾病严重程度的相关性。方法选择2012年1月至2014年1月湖北医药学院附属太和医院产科收治的86例HDCP患者为研究组,其中妊娠期高血压组36例、轻度子痫前期组18例和重度子痫前期组32例,选取同期正常妊娠晚期孕妇60例为对照组。采用免疫组化(SP)法检测各组胎盘中MMP-1、TIMP-1的表达;酶联免疫吸附法(ELISA)检测脐血血清中MMP-1、TIMP-1的表达。结果胎盘中MMP-1在对照组、妊娠期高血压组、轻度子痫前期组、重度子痫前期组的阳性表达率分别为96.7%、77.8%、66.7%、23.1%;4组脐血血清中MMP-1的表达分别为(294.33±11.53)pg/m L、(247.78±20.32)pg/m L、(177.67±12.63)pg/m L、(124.68±15.41)pg/m L,4组间两两比较差异均有统计学意义(P<0.05)。4组胎盘和脐血血清中TIMP-1的表达差异无统计学意义(P>0.05)。结论 MMP-1与HDCP的发生和疾病严重程度之间存在相关性。 Objective To investigate the relationship between the expression of matrix metallopreteinases - 1 ( MMP - 1 ), tissue inhibitor of metaUoproteinases - 1 ( TIMP - 1 ) and hypertensive disorder complicating pregnancy (HDCP). Methods The 86 patients with HDCP in Taihe Hospital Affiliated to Hubei Medical College from Jan 2012 to Jan 2014 were enrolled as the study group, including 36 patients with gestational hypertension were as gestational hypertension group, 18 cases with mild preeclampsia were as mild preeclampsia group, and 32 cases with severe preeclampsia were as severe preeclampsia group. 60 normal pregnant women were collected as control group. Immunohistochemistry was used to analyze MMP - 1 and TIMP - 1 in placenta. Enzyme linked immunosorbent assay was used to analyze the expression of MMP - 1 and TIMP - 1 in umbilicus serum. Results In the placenta, the rate of positive expression of MMP - 1 of control group, gestational hypertension group, preeclampsia group, severe preeclampsia group were 96. 7 %, 77. 8 %, 66. 7 % and 23.1% respectively. In umbilicus serum, the MMP - 1 of control group gestational, hypertension group, preeclampsia group, severe preeclampsia group were (294. 33 ± 11. 53 ) pg/mL, (247. 78±20. 32 ) pg/mL, ( 177. 67±12. 63 ) pg/mL and ( 124. 68±15.41 ) pg/mL respectively, there were significant differences between groups ( P 〈 0. 05 ). But there was no statistically significant difference between groups in the expression of TIMP - 1 (P 〉 0. 05). Conclusion There is a close relationship between the expression of MMP - 1 and HDCP.
出处 《中国计划生育和妇产科》 2015年第11期62-65,共4页 Chinese Journal of Family Planning & Gynecotokology
关键词 妊娠期高血压疾病 胎盘 脐血血清 基质金属蛋白酶-1 基质金属蛋白酶抑制因子-1 hypertensive disorder complicating pregnancy placenta umbilicus serum matrix Metalloproteinases -1 tissue inhibitor of Metalloproteinases - 1
  • 相关文献

参考文献11

  • 1谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 2OTA H, IGARASHI SASAKI M, et al. Distribution of cyclooxygenase -2 in eutopic and eetopic endometrium in endometriosis and adenomyosis [ J ]. Human Reproduction, 2001, 16 (3): 561 -566.
  • 3RAFFETrO J, KHALIL R. Matrix metalloproteinase and their inhibitors in vascular remodeling and vascular disease [ J ]. Biochemical Pharmacology, 2008, 75 (2): 346-359.
  • 4MIYAKE H, HARA I, GOHJI K, et al. Relative expression of matrix metallpreteinase - 2 and tissue inhibitor of matrix meta/loproteinase- 2 in mouse renal cell carcinoma cells regulates their metastatic potential [ J ]. Clinical Cancer Research, 1999, 5 (10) : 2824-2829.
  • 5RAFFETTO J D, KHALIL R A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease [ J ]. Biochemical Pharmacology, 2008, 75 (2) : 346 - 359.
  • 6NAKANO M, HARA T, HAYAMA T, et al. Membrane -type 1 matrix metalloproteinase is induced in decidual stroma without direct invasion by trophoblasts [ J ]. Molecular Human Reproduction, 2001,7 (3) : 271 -277.
  • 7Hurskainen T, Seiki M, Apte SS, et al. Production of Membrane - type Matrix Metalloproteinase - 1 ( MT - MMP - 1 ) in Early Human Placenta: Possible Role in Placental Implantation ? [ J ]. J Histochem Cytochem, 1998, 46 (2) : 221 -229.
  • 8Tayebjee MH, Karalis I, Nadar SK, et al. Circulating matrix metalloproteinase- 9 end tissue inhibitor of metalloproteinases - 1 and- 2 levels in gestational hypertension [ J ]. Am J Hypertens, 2005, 18 (3) : 325 -329.
  • 9Shih leM and Kurman ILl. Molecular basis of gestational trephoblastic diseases [ J]. Curr Mol Med, 2002, 2:1 -12.
  • 10LIAN LA, TOFT JH, OLSEN GD, et al. Matrix metalloproteinase 1 in pre -eelampsia and fetal growth restriction: reduced gene expression in decidual tissue and protein expression in extravillous trephoblasts [J]. Placenta, 2010, 31 (7): 615-620.

共引文献856

同被引文献23

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部